In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Echo Therapeutics Inc. (NASDAQ:ECTE) reported that Schoenbart Alan Wayne has picked up 774,500 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Schoenbart Alan Wayne to a total of 774,500 representing a 5.6% stake in the company.
For those not familiar with the company, Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.
A glance at Echo Therapeutics Inc. (NASDAQ:ECTE)’s key stats reveals a current market capitalization of 1.68 Million based on 12.00 Million shares outstanding and a price at last close of $0.140 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-20-20, Schoenbart picked up 2,500 at a purchase price of $1.44. This brings their total holding to 2,500 as of the date of the filing.
On the sell side, the most recent transaction saw Young unload 10,000 shares at a sale price of $2.38. This brings their total holding to 160,874.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Echo Therapeutics Inc. (NASDAQ:ECTE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
